News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–17
Matches
17
Sources here
8
Companies here
1
Search results Stored financial headlines

Active search

17 matching headlines

Ticker or company: HKPDMain company stories
Clear
Latest

TradingKey Earnings

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Stock News Today

This article provides current stock information for Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its recent trading price, market capitalization, and a note that more news is coming soon. It serves as a placeholder for updates regarding earnings, analyst ratings, and key developments related to HKPD.

Hong Kong Pharma Digital Technology Holdings Ltd

This page provides an overview of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its stock performance, market capitalization, and financial forecasts for EPS and revenue. It also lists peer comparisons with other pharmaceutical companies like Amgen Inc and Eli Lilly and Co, …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Balance Sheet

This article provides a detailed balance sheet for Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), presenting quarterly and annual financial data for assets, liabilities, and shareholders' equity. It includes specific figures for various financial components like cash, receivables, inventory, current and non-current assets, …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Cash Flow

This article provides an overview of Hong Kong Pharma Digital Technology Holdings Ltd's (HKPD) cash flow, including operating, investing, and financing activities. It details the company's operating cash flow for fiscal 2025, capital expenditures in the latest quarter, and financing cash flow usage. The …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HKPD Hong Kong Pharma Digital Technology Holdings Ltd Financials

This article provides a detailed financial overview of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its market performance, key financial indicators, and earnings report data. It features data from the company's FY2025 earnings, covering revenue, EPS, assets, liabilities, and various financial ratios. …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Income Statement - Tradingkey.com

This article from TradingKey.com provides the income statement for Hong Kong Pharma Digital Technology Holdings Ltd (HKPD). It details key financial metrics such as revenue, net income, and operating profit for fiscal year 2025, along with FAQs explaining how to interpret income statements and …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Institutional Confidence

This article provides details on the institutional confidence in Hong Kong Pharma Digital Technology Holdings Ltd (HKPD). It lists major shareholders and their current holdings, including any changes in share percentages. The data highlights key institutional and individual investors and their stakes in the …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Financial Health: Profitability & Balance Sheet Analysis

This article focuses on the financial health of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), specifically exploring its profitability and balance sheet. It presents key financial data including market capitalization and a historical stock price and percentage change. The article indicates that HKPD …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HKPD|Hong Kong Pharma Digital Technology Holdings Ltd|Price:0.365|Chg%:+0.034

This article provides an overview of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its current stock price and key financial indicators. It details how TradingKey generates its comprehensive stock score based on various financial health, company valuation, earnings forecast, price momentum, institutional …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension

Cellyan Biotechnology (HKPD) has been granted an additional 180-day grace period by Nasdaq until January 11, 2027, to regain compliance with the minimum $1.00 bid price requirement. The company must maintain a closing bid price of at least $1.00 per share for ten consecutive …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period

Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) has received an additional 180-day grace period from Nasdaq, extending until January 11, 2027, to regain compliance with the minimum $1.00 closing bid price requirement. The company must maintain a closing bid price of at least $1.00 for …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11

Cellyan Biotechnology (Nasdaq: HKPD) announced it has received a 180-day extension from Nasdaq, until January 11, 2027, to regain compliance with the $1.00 minimum closing bid price requirement. To meet this, the company's Class A ordinary shares must close at $1.00 or higher for …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened

Cellyan Biotechnology Co. Ltd (NASDAQ: HKPD) shares dropped over 20% in after-hours trading after the company announced it received an additional 180-day compliance period from Nasdaq to meet the minimum $1.00 bid price requirement. The company must maintain a closing bid price of at …

HKPD main company
Sharemaestro market context Price below Trend Line 52 weeks -59.6% · Next-week setup negative 38.1% HKPD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context